About Enki Life Science Limited
Data last updated:
Enki Life Science Limited is a public limited company based in Thane, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 June 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74110MH2000PLC127327. Its GSTIN is 27AAFCS5435H1Z8 (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.72 Cr. It was formerly known as Sharon Biotech Limited. It is led by directors including Vineeta Bulusu and Prashant Ghildiyal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5A Bsel Tech Park, Sector 30, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.28 Cr, a decline of 59% compared to the previous year. For the same year it recorded a net loss of ₹5.71 Cr (net margin -445.5%) and EBITDA of -₹5.49 Cr (EBITDA margin -428.4%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 16 cases involving the company, including 13 filed by the company and 3 filed against it; 8 cases are pending. The company has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹6.23 Cr; the latest was in March 2015. Its 3 peer companies in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (plastic products, non-metallic mineral products, rubber products, fabricated metal products) are compared by revenue, 1 larger and 2 smaller; the largest is Safron Pharmaceuticals Private Limited with revenue of ₹1.28 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enkilife.com.
Company details
CIN history
Enki Life Science has one previous CIN (Corporate Identification Number): U73100MH2000PLC127327. The current CIN is U74110MH2000PLC127327, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110MH2000PLC127327 | Current |
| U73100MH2000PLC127327 | Previous |
Contact details
Enki Life Science Limited's registered office is in Thane, Maharashtra. Its website is enkilife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No 310/312 Plot No 39/5 39/5A Bsel Tech Park, Sector 30A Opp Vashi Railway Station Vashi, Thane, Maharashtra, India – 400703
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Enki Life Science Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Enki Life Science Limited
FY 2024 filings availableEnki Life Science Limited reported revenue of ₹1.28 Cr (down 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 59% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -428.4% | ||||
| Net Profit Margin | -445.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enki Life Science Limited, buy the company report.
Board of directors of Enki Life Science Limited
Enki Life Science has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vineeta Bulusu | Director | 13 Jan 2015 | 11 Years 9 Months | Current |
| Preeti Shambhuprasad Misra Also directs: Bagulvani General Trading Private Limited, Ramco Properties Private Limited, Nesh Pharmatech Private Limited and 2 more | Additional Director | 17 Apr 2025 | 1 Years 6 Months | Current |
| Prashant Ghildiyal | Director | 30 Sep 2017 | 9 Years 0 Months | Current |
Peer comparison
Enki Life Science Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (plastic products, non-metallic mineral products, rubber products, fabricated metal products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Safron Pharmaceuticals Private Limited | ₹1.28 Cr (FY 2024) | -41.0% | Mumbai, Maharashtra, India | |||
| Enki Life Science Limitedthis company | ₹1.28 Cr (FY 2025) | -₹5.71 Cr | -445.5% | -59.0% | Thane, Maharashtra, India | |
| Solar Chemicals (Kanpur) Private Limited | ₹1.28 Cr (FY 2025) | -10.0% | Kanpur, Uttar Pradesh, India | |||
| Medopharm Wellness Private Limited | ₹1.28 Cr (FY 2025) | 10.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Enki Life Science Limited, buy the company report.
Auditor
Enki Life Science Limited is audited by H L SAINI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H L SAINI & CO | FY 2023 | 136961W |
Shareholding
The shareholding of Enki Life Science Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enki Life Science Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jan 2006 | 90371909 | Uti Bank Ltd. | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Enki Life Science Limited has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹6.23 Cr; the latest was in March 2015.
Deals on record (5 of 11)
To see the full deal history of Enki Life Science Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Enki Life Science Limited has 16 court cases on record: 13 filed by Enki Life Science, 3 filed against it. 8 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 8 | 0 | 6 |
| High courts | 5 | 0 | 0 |
| District courts | 2 | 2 | 2 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT New Delhi | Insolvency matter | Filed by the company against Satra Properties India Limited and 5 others | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SPL.CASE) | Filed against the company by an individual | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Police cases PW) | Filed against the company by an individual | Pending |
To see the full case history of Enki Life Science Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enki Life Science Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Enki Life Science Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Enki Life Science has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCS5435H1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enki Life Science Limited, buy the company report.
Recent activity
Enki Life Science Limited has 14 board changes on record since 2012: 4 appointments and 10 cessations. The latest: Preeti Shambhuprasad Misra was appointed as Additional Director on 17 Apr 2025.
6 earlier events are in the company report.
Frequently asked questions
Enki Life Science is an active public limited company based in Thane, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 June 2000 (26+ years old) and is registered under CIN U74110MH2000PLC127327.
Enki Life Science has 3 current directors:
- Vineeta Bulusu - Director
- Preeti Shambhuprasad Misra - Additional Director
- Prashant Ghildiyal - Director
The latest financial statements of Enki Life Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Enki Life Science is 27AAFCS5435H1Z8, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Enki Life Science is U74110MH2000PLC127327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enki Life Science has 16 court cases on record: 13 filed by the company and 3 filed against it. 8 are pending. Most are in the nclat.
Enki Life Science was incorporated on 22 June 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Enki Life Science has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹6.23 Cr; the latest was in March 2015.
The peers of Enki Life Science by revenue are Safron Pharmaceuticals Private Limited, Solar Chemicals (Kanpur) Private Limited, Medopharm Wellness Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (plastic products, non-metallic mineral products, rubber products, fabricated metal products).
Preeti Shambhuprasad Misra was appointed as Additional Director on 17 Apr 2025. Rajendra Prasad Kalika Prasad Sharma ceased to be Additional Director on 31 Dec 2020. Rajendra Prasad Kalika Prasad Sharma was appointed as Director on 07 Sep 2020. Enki Life Science has 14 board changes on record in total.
Enki Life Science can be reached through the website enkilife.com. Its registered office is in Thane, Maharashtra, India.